John Smyth MA, MBBChir, MD

John Smyth is Emeritus Professor of Medical Oncology at the University of Edinburgh, where his major research interest has been the development and evaluation of new anti-cancer drugs. He has published over 300 papers and is past Editor-in-Chief of the European Journal of Cancer.

He served for several years on the UK Committee on Safety of Medicines; currently, Chair’s the Expert Advisory Group for Oncology & Haematology for the Commission on Human Medicines and has served on the Scientific Advisory Group for Oncology to the EMEA.

He is a fellow of the Royal College of Physicians of Edinburgh and London, and a fellow of the Royal Society of Edinburgh. He is a past-president of the European Society of Medical Oncology and was from 2005 – 2007 President of the Federation of European Cancer Societies.